Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.63NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
XBB.1.5.9NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
DT.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
AY.5.4 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
AY.5.5 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
AY.5 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
BN.1.2.8NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
AY.5.2 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
AY.5.6 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
AY.5.3 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
B.1.467NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
AY.5.1 (Delta)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-17791.8Hong Kong
JN.1.62NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-17792.3Thailand
MK.2ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
XBB.1.5ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
KP.2.3.4ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
HV.1.4ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
XCTORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
B.1.404ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
B.1.617.3ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
B.1.1.309ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
B.1.1.280ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
XBB.1.5.74ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
AE.5ORF1abNIID WH-1 F509R854CAGAAGTTGTTATCGACATAGC2240.91837816R-17798.2Japan
B.1.160.9ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
B.31ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
JD.1.1.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
LL.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
B.1.1.268ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
XBB.1.5.11ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
JN.1.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
AY.91.1 (Delta)ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
CH.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
FL.19ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
JB.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
XBB.1.5.54ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-17837South Korea
FS.1ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
XBB.1.5.54ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
BF.29ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
BA.5.2.29ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
N.5ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
P.1.15 (Gamma)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.575ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
C.26ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
Q.4 (Alpha)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.1.442ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
P.1.1 (Gamma)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
A.2.5.2ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
B.1.600ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
P.1.12 (Gamma)ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used